Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

23. März 2026 16:05 ET | Quelle: Abivax

Abivax Announces Full Year 2025 Financial Results and Provides Business Updates

Abivax Announces Full Year 2025 Financial Results and Provides Business Updates ABTECT Phase 3 Data Safety Monitoring Board (DSMB) meeting on March 18, 2026 found no new safety signals; the analysis...
23. März 2026 16:00 ET | Quelle: Levi & Korsinsky, LLP

Levi & Korsinsky Reminds Corcept Therapeutics Incorporated Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 21, 2026 – CORT

NEW YORK, March 23, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Corcept Therapeutics Incorporated ("Corcept Therapeutics Incorporated" or the "Company") (NASDAQ: CORT)...
23. März 2026 16:00 ET | Quelle: Levi & Korsinsky, LLP

AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Misrepresented Anaphylm's FDA Approval Prospects: Levi & Korsinsky

Promise vs. Reality: The Aquestive Therapeutics Performance Gap Management told investors Anaphylm was "on track" for FDA approval by January 31, 2026. On January 9, 2026, the FDA flagged...
23. März 2026 13:00 ET | Quelle: YZi Labs

YZi Labs Highlights Systemic Governance Breakdown at CEA Industries; Condemns Nearly $2 Million "Golden Parachute" for Outgoing CEO David Namdar Amidst Disclosed Material Weaknesses

Recent Filings Document a Catastrophic Failure of Internal Controls, Including a Lack of Segregation of Duties between the CEO and Accounting Functions YZi Labs Breaks Down the Seemingly Egregious...